title: High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.
abstract: Chromosomal regions harboring tumor suppressors and oncogenes are often deleted or amplified. Array comparative genomic hybridization detects segmental DNA copy number alterations in tumor DNA relative to a normal control. The recent development of a bacterial artificial chromosome array, which spans the human genome in a tiling path manner with >32,000 clones, has facilitated whole genome profiling at an unprecedented resolution. Using this technology, we comprehensively describe and compare the genomes of 28 commonly used non-small cell lung carcinoma (NSCLC) cell models, derived from 18 adenocarcinomas (AC), 9 squamous cell carcinomas and 1 large cell carcinoma. Analysis at such resolution not only provided a detailed genomic alteration template for each of these model cell lines, but revealed novel regions of frequent duplication and deletion. Significantly, a detailed analysis of chromosome 7 identified 6 distinct regions of alterations across this chromosome, implicating the presence of multiple novel oncogene loci on this chromosome. As well, a comparison between the squamous and AC cells revealed alterations common to both subtypes, such as the loss of 3p and gain of 5p, in addition to multiple hotspots more frequently associated with only 1 subtype. Interestingly, chromosome 3q, which is known to be amplified in both subtypes, showed 2 distinct regions of alteration, 1 frequently altered in squamous and 1 more frequently altered in AC. In summary, our data demonstrate the unique information generated by high resolution analysis of NSCLC genomes and uncover the presence of genetic alterations prevalent in the different NSCLC subtypes.
authors.affiliation: British Columbia Cancer Research Centre, Vancouver, BC, Canada. cgarnis@bccrc.ca
authors.forename: Cathie
authors.initials: C
authors.lastname: Garnis
authors.forename: William W
authors.initials: WW
authors.lastname: Lockwood
authors.forename: Emily
authors.initials: E
authors.lastname: Vucic
authors.forename: Yong
authors.initials: Y
authors.lastname: Ge
authors.forename: Luc
authors.initials: L
authors.lastname: Girard
authors.forename: John D
authors.initials: JD
authors.lastname: Minna
authors.forename: Adi F
authors.initials: AF
authors.lastname: Gazdar
authors.forename: Stephen
authors.initials: S
authors.lastname: Lam
authors.forename: Calum
authors.initials: C
authors.lastname: MacAulay
authors.forename: Wan L
authors.initials: WL
authors.lastname: Lam
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000473:pathology; D045744:Cell Line, Tumor; D022202:Chromosomes, Artificial, Bacterial / Q000235:genetics; D005784:Gene Amplification; D018628:Gene Dosage; D020869:Gene Expression Profiling; D015894:Genome, Human / Q000235:genetics*; D006801:Humans; D019656:Loss of Heterozygosity; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology; D046228:Microarray Analysis / Q000379:methods; D009693:Nucleic Acid Hybridization / Q000379:methods*